Stay updated with breaking news from Strides Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Among smallcaps, Kaveri Seed was LIC ownership reducing by about half to 2.66% in Q3. In MOIL, LIC stake fell from 7.42% to 5.46% quarter-on-quarter, shows ACE Equity data.
Listed pharmaceuticals player Eris Lifesciences Ltd has acquired 51% stake in sterile injectables company Swiss Parenterals for Rs 637.5 crore (around $76.7 million), thus foraying ......
Bajaj Finance sold 0.88 percent stake in Strides Pharma Science and Amansa Holding bought 1.24 percent stake.
Around 11.40 lakh shares were sold, which represent a 1.24 per cent stake in the company. The shares were sold at an average price of Rs 713 per piece, taking the combined transaction value to Rs 81.30 crore.
Sharekhan is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 800 in its research report dated January 30, 2024.